Announced investment in India's Ayush & Herbal Medicine segment has crossed $9.8 billion, with 1,073 projects at various stages of approval, according to an IGEN tracker of public filings and ministry disclosures. About a third have secured land and power, a quarter have placed major equipment orders, and the rest remain in planning.

Reliance Industries is among the most visible movers. The company said it will invest $9.8 billion over the next four years to build capacity targeting export customers in Singapore and Germany, with first commercial output expected in Q4 FY27. Management described the project as a response to customers seeking a credible second source.

The investment picture

Government support is substantial but conditional. The central scheme offers up to half of eligible project cost for qualifying units, and several states layer on capital subsidies and power-tariff concessions. Officials say disbursement timelines have improved, with the first tranche released 60 days after milestone certification.

The binding constraints are practical. Specialised equipment has lead times of 12 to 18 months, reliable high-grade power is concentrated in a handful of industrial parks, and the sector needs an estimated 1,073 additional trained engineers over three years. Training institutes are expanding, but the gap is real.

Customers abroad are conducting audits at a pace that surprised suppliers. Delegations from Singapore visited 1,073 sites this year, and qualification cycles that once took 24 months are being compressed to 14 where the supplier can show a stable process and traceable materials.

“The customers will tell you who is serious: qualification cycles shorten only for suppliers with stable processes.”

Constraints that decide timing

Environmental performance is entering the conversation. Buyers increasingly ask for energy-use and water-use data, and several projects are designing for renewable power from day one. That adds cost up front but is becoming a condition for premium customers.

The outlook is positive, with caveats. If even two-thirds of announced projects proceed on time, India's share of the global segment could double by 2030. If equipment, power or talent constraints slip, analysts say the first wave of capacity could arrive 12 months late.

Partnerships, funding and customers

Funding is available but selective. Venture and private-equity investors committed $370 million to the segment in the past two quarters, with a preference for companies that already hold customer qualification. Banks are lending against contracted offtake rather than promised capacity.

Early operational results from pilot lines are encouraging. One facility reported yields reaching 33.5% within six months of start-up, ahead of internal targets, and a second said that automation cut its defect rate by 7.7%. Executives caution that scaling from pilot to volume is where most projects face their first real test.

What success looks like by 2030

The software layer is attracting attention too. Plant operators report that predictive-maintenance and quality-vision systems have reduced unplanned downtime by 13.9%, and a growing cohort of startups sells these tools as a subscription. Procurement teams say integration with legacy equipment is the largest hurdle.